BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Jia A, Bi Y, Wang Y, Yang Q, Cao Y, Li Y, Liu G. Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy. Cancers (Basel) 2020;12:E2626. [PMID: 32942545 DOI: 10.3390/cancers12092626] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Rytlewski J, Milhem MM, Monga V. Turning 'Cold' tumors 'Hot': immunotherapies in sarcoma. Ann Transl Med 2021;9:1039. [PMID: 34277839 DOI: 10.21037/atm-20-6041] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
2 Xing Y, Ruan G, Ni H, Qin H, Chen S, Gu X, Shang J, Zhou Y, Tao X, Zheng L. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression. Front Immunol 2021;12:624725. [PMID: 34084160 DOI: 10.3389/fimmu.2021.624725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zalfa C, Paust S. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy. Front Immunol 2021;12:633205. [PMID: 34025641 DOI: 10.3389/fimmu.2021.633205] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
4 Kaur J, Mir T, Gill R, Duong J, Marcus S, Khan R. Immunotherapeutic approach for advanced pancreatic adenocarcinoma. Immunotherapy 2021;13:767-82. [PMID: 33910383 DOI: 10.2217/imt-2020-0344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Asiry S, Kim G, Filippou PS, Sanchez LR, Entenberg D, Marks DK, Oktay MH, Karagiannis GS. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy. Front Immunol 2021;12:654877. [PMID: 33927723 DOI: 10.3389/fimmu.2021.654877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mojsilovic S, Mojsilovic SS, Bjelica S, Santibanez JF. Transforming growth factor-beta1 and myeloid-derived suppressor cells: A cancerous partnership. Dev Dyn 2021. [PMID: 33797140 DOI: 10.1002/dvdy.339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jalalvand M, Darbeheshti F, Rezaei N. Immune checkpoint inhibitors: review of the existing evidence and challenges in breast cancer. Immunotherapy 2021;13:587-603. [PMID: 33775102 DOI: 10.2217/imt-2020-0283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang J, Zhang Y, Qu B, Yang H, Hu S, Dong X. If small molecules immunotherapy comes, can the prime be far behind? Eur J Med Chem 2021;218:113356. [PMID: 33773287 DOI: 10.1016/j.ejmech.2021.113356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lahmar Q, Schouppe E, Morias Y, Van Overmeire E, De Baetselier P, Movahedi K, Laoui D, Sarukhan A, Van Ginderachter JA. Monocytic myeloid-derived suppressor cells home to tumor-draining lymph nodes via CCR2 and locally modulate the immune response. Cell Immunol 2021;362:104296. [PMID: 33556903 DOI: 10.1016/j.cellimm.2021.104296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Baram T, Rubinstein-Achiasaf L, Ben-Yaakov H, Ben-Baruch A. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy. Front Oncol 2020;10:614468. [PMID: 33585241 DOI: 10.3389/fonc.2020.614468] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
11 Jia A, Wang Y, Wang Y, Li Y, Yang Q, Cao Y, He Y, Dong L, Dong Y, Hou Y, Wang R, Bi Y, Liu G. The kinase AKT1 potentiates the suppressive functions of myeloid-derived suppressor cells in inflammation and cancer. Cell Mol Immunol 2021;18:1074-6. [PMID: 33462382 DOI: 10.1038/s41423-020-00610-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Török N, Tanaka M, Vécsei L. Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway. Int J Mol Sci 2020;21:E9338. [PMID: 33302404 DOI: 10.3390/ijms21249338] [Cited by in Crossref: 17] [Cited by in F6Publishing: 46] [Article Influence: 8.5] [Reference Citation Analysis]
13 Kabelitz D. Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran. Cells 2020;9:E2564. [PMID: 33266147 DOI: 10.3390/cells9122564] [Cited by in F6Publishing: 2] [Reference Citation Analysis]